Clinical Laboratory Improvement Advisory Committee, 32349 [E6-8715]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 107 / Monday, June 5, 2006 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier: OS–0990–0169; 30day notice]
cprice-sewell on PROD1PC66 with NOTICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
of Health and Human Services, is
publishing the following summary of a
proposed collection for public
comment. Interested persons are invited
to send comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Type of Information Collection
Request: Regular Clearance, Extension
of a currently approved collection;
Title of Information Collection:
Uniform Administrative Requirements
for Grantors and Cooperative
Agreements to State and Local
Governments;
Form/OMB No.: OS–0990–0169;
Use: Pre-Award, Post-Award, and
subsequent reporting and recordkeeping
requirements are necessary to award,
monitor, close out and managers grant
programs, ensure minimum fical control
and accountability for Federal funds
and deter fraud, waste and abuse.
Frequency: Reporting, on occasion;
Affected Public: Business or other forprofit, not-for-profit institutions, and
Federal government;
Annual Number of Respondents:
4,000;
Total Annual Responses: 4,000;
Average Burden Per Response: 70
hours;
Total Annual Hours: 280,000;
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access the HHS Web
site address at https://www.hhs.gov/ocio/
infocollect/pending/ or e-mail your
request, including your address, phone
number, OMB number, and OS
document identifier, to
VerDate Aug<31>2005
15:33 Jun 02, 2006
Jkt 208001
Sherette.funncoleman@hhs.gov. or call
the Reports Clearance Office on (202)
690–6162. Written comments and
recommendations for the proposed
information collections must be
received within 30 days of this notice
directly to the Desk Officer at the
address below: OMB Desk Officer: John
Kraemer, OMB Human Resources and
Housing Branch, Attention: (OMB
#0990–0169), New Executive Office
Building, Room 10235, Washington, DC
20503.
Dated: May 26, 2006.
Robert E. Polson,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 06–5076 Filed 6–2–06; 8:45 am]
BILLING CODE 4150–24–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Name: Clinical Laboratory Improvement
Advisory Committee (CLIAC).
Times and Dates: 8:30 a.m.–5 p.m., June
20, 2006. 8:30 a.m.–3 p.m., June 21, 2006.
Place: Sheraton Midtown Atlanta Hotel at
Colony Square, 188 14th Street, NE., Atlanta,
Georgia 30361, Telephone: (404) 892–6000.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This Committee is charged with
providing scientific and technical advice and
guidance to the Secretary of Health and
Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the
need for, and the nature of, revisions to the
standards under which clinical laboratories
are regulated; the impact on medical and
laboratory practice of proposed revisions to
the standards; and the modification of the
standards to accommodate technological
advances.
Matters To Be Discussed: Updates from
CDC, the Centers for Medicare & Medicaid
Services, and the Food and Drug
Administration; presentations and discussion
concerning gynecologic cytology laboratory
practice and proficiency testing; and a report
from the CLIAC Cytology Proficiency Testing
Workgroup and discussion of the
Workgroup’s proposals related to such.
Agenda items are subject to change as
priorities dictate.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
32349
public comments whenever possible. Oral
Comments: In general, each individual or
group requesting to make an oral
presentation will be limited to a total time of
five minutes (unless otherwise indicated).
Speakers must also submit their comments in
writing for inclusion in the meeting’s
Summary Report. To assure adequate time is
scheduled for public comments, individuals
or groups planning to make an oral
presentation should, when possible, notify
the contact person below at least one week
prior to the meeting date. Written Comments:
For individuals or groups unable to attend
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated). However, the
comments should be received at least one
week prior to the meeting date so that the
comments may be made available to the
Committee for their consideration and public
distribution. Written comments, one hard
copy with original signature, should be
provided to the contact person below.
Written comments will be included in the
meeting’s Summary Report.
Contact Person for Additional Information:
Devery Howerton, Acting Chief, Laboratory
Practice Standards Branch, Division Public
Health Partnerships—Laboratory Systems,
National Center for Health Marketing,
Coordinating Center for Health Information
and Service, CDC, 1600 Clifton Road, NE.,
Mailstop G–23, Atlanta, Georgia 30333;
telephone (404) 718–1016; fax (404) 718–
1080; or via e-mail at DHowerton@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register.
Notices pertaining to announcements of
meetings and other committee management
activities, for CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 30, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–8715 Filed 6–2–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 71 FR 20403, dated
April 20, 2006) is amended to reflect the
establishment of the Library Services
Most Efficient Organization with the
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 71, Number 107 (Monday, June 5, 2006)]
[Notices]
[Page 32349]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-8715]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Name: Clinical Laboratory Improvement Advisory Committee
(CLIAC).
Times and Dates: 8:30 a.m.-5 p.m., June 20, 2006. 8:30 a.m.-3
p.m., June 21, 2006.
Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th
Street, NE., Atlanta, Georgia 30361, Telephone: (404) 892-6000.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This Committee is charged with providing scientific and
technical advice and guidance to the Secretary of Health and Human
Services, the Assistant Secretary for Health, and the Director, CDC,
regarding the need for, and the nature of, revisions to the
standards under which clinical laboratories are regulated; the
impact on medical and laboratory practice of proposed revisions to
the standards; and the modification of the standards to accommodate
technological advances.
Matters To Be Discussed: Updates from CDC, the Centers for
Medicare & Medicaid Services, and the Food and Drug Administration;
presentations and discussion concerning gynecologic cytology
laboratory practice and proficiency testing; and a report from the
CLIAC Cytology Proficiency Testing Workgroup and discussion of the
Workgroup's proposals related to such. Agenda items are subject to
change as priorities dictate.
Providing Oral or Written Comments: It is the policy of CLIAC to
accept written public comments and provide a brief period for oral
public comments whenever possible. Oral Comments: In general, each
individual or group requesting to make an oral presentation will be
limited to a total time of five minutes (unless otherwise
indicated). Speakers must also submit their comments in writing for
inclusion in the meeting's Summary Report. To assure adequate time
is scheduled for public comments, individuals or groups planning to
make an oral presentation should, when possible, notify the contact
person below at least one week prior to the meeting date. Written
Comments: For individuals or groups unable to attend the meeting,
CLIAC accepts written comments until the date of the meeting (unless
otherwise stated). However, the comments should be received at least
one week prior to the meeting date so that the comments may be made
available to the Committee for their consideration and public
distribution. Written comments, one hard copy with original
signature, should be provided to the contact person below. Written
comments will be included in the meeting's Summary Report.
Contact Person for Additional Information: Devery Howerton,
Acting Chief, Laboratory Practice Standards Branch, Division Public
Health Partnerships--Laboratory Systems, National Center for Health
Marketing, Coordinating Center for Health Information and Service,
CDC, 1600 Clifton Road, NE., Mailstop G-23, Atlanta, Georgia 30333;
telephone (404) 718-1016; fax (404) 718-1080; or via e-mail at
DHowerton@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register.
Notices pertaining to announcements of meetings and other
committee management activities, for CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 30, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-8715 Filed 6-2-06; 8:45 am]
BILLING CODE 4163-18-P
